Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
American Journal of Hematology
|
March 27, 2024
Bleeding self-assessments by patients with immune thrombocytopenia (ITP): An agreement study
Bianca Clerici, Sahrish Masood, Ishac Nazy, et al.
Vox Sanguinis
|
May 25, 2019
Sex-mismatched red blood cell transfusions and mortality: A systematic review and meta-analysis
Michelle P Zeller, Bram Rochwerg, Erin Jamula, et al.
Transfusion
|
October 26, 2022
A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma
Na Li, Michelle P Zeller, Andrew W Shih, et al.
Blood Advances
|
November 15, 2021
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia
Manraj N Kaur, Donald M Arnold, Nancy M Heddle, et al.
Thrombosis and Haemostasis
|
January 28, 2019
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale
Donald M Arnold, Erin Jamula, Nancy M Heddle, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
March 28, 2024
Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada
Joanne Britto, Anne Holbrook, Haowei Sun, et al.
Transfusion
|
February 7, 2024
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCE
Rena Buckstein, Jeannie Callum, Anca Prica, et al.
Transfusion
|
March 21, 2024
Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trial
Preston Tse, Jiajun Yan, Yang Liu, et al.
The Lancet. Haematology
|
August 28, 2020
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial
Donald M Arnold, Nancy M Heddle, Richard J Cook, et al.
American Journal of Hematology
|
December 21, 2023
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies
Rena Buckstein, Jeannie Callum, Anca Prica, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
American Journal of Hematology
|
March 27, 2024
Bleeding self-assessments by patients with immune thrombocytopenia (ITP): An agreement study
Bianca Clerici, Sahrish Masood, Ishac Nazy, et al.
Vox Sanguinis
|
May 25, 2019
Sex-mismatched red blood cell transfusions and mortality: A systematic review and meta-analysis
Michelle P Zeller, Bram Rochwerg, Erin Jamula, et al.
Transfusion
|
October 26, 2022
A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma
Na Li, Michelle P Zeller, Andrew W Shih, et al.
Blood Advances
|
November 15, 2021
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia
Manraj N Kaur, Donald M Arnold, Nancy M Heddle, et al.
Thrombosis and Haemostasis
|
January 28, 2019
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale
Donald M Arnold, Erin Jamula, Nancy M Heddle, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
March 28, 2024
Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada
Joanne Britto, Anne Holbrook, Haowei Sun, et al.
Transfusion
|
February 7, 2024
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCE
Rena Buckstein, Jeannie Callum, Anca Prica, et al.
Transfusion
|
March 21, 2024
Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trial
Preston Tse, Jiajun Yan, Yang Liu, et al.
The Lancet. Haematology
|
August 28, 2020
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial
Donald M Arnold, Nancy M Heddle, Richard J Cook, et al.
American Journal of Hematology
|
December 21, 2023
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies
Rena Buckstein, Jeannie Callum, Anca Prica, et al.
Page
of 3